Physician profile
David Harvey
NPI 1578526232
$16,998.53
in general payments reported to CMS, 2019-2025
39 companies · $6,006 in 2025
The $6,006 reported for 2025 was more than what 94% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,437 · 2020: $244 · 2021: $820 · 2022: $355 · 2023: $1,351 · 2024: $786 · 2025: $6,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,162 · Food and Beverage: $2,974 · Education: $7.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,161.50 |
| Food and Beverage | $2,974.08 |
| Education | $7.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $6,750.18 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $5,410.70 | 2020-2025 | Libtayo, Dupixent |
| Merz North America, INC. | $1,100.18 | 2021-2023 | Xeomin |
| Genzyme Corporation | $707.77 | 2021-2025 | |
| Abbvie INC. | $307.60 | 2020-2025 | |
| Amgen INC. | $245.40 | 2022-2025 | Otezla, Otezla |
| Arcutis Biotherapeutics, INC. | $226.13 | 2023-2024 | Zoryve |
| Biofrontera INC. | $214.19 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $203.45 | 2019-2025 | Odomzo, Blu-U |
| Lilly USA, LLC | $201.70 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Kerecis Limited | $176.64 | 2021-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Surgenex LLC | $160.56 | 2025 | Surgraft, Ardeograft, Pellograft |
| Ironshore Pharmaceuticals INC. | $122.33 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $121.10 | 2020-2025 | |
| Janssen Biotech, INC. | $94.92 | 2019-2025 | Tremfya |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Harvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.